JPRN-UMIN000016117已完成未知
Effects of Tocilizumab on Bone Metabolism, RANKL, osteoprotegerin, DKK-1 and osteopontin in Rheumatoid Arthritis. - Effects of Biologics DMARDs on Bone Metabolism in Rheumatoid Arthritis.
Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine0 个研究点目标入组 60 人开始时间: 2018年3月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Case outside the patient who can't get consent in a test and the adaptation by a guideline
研究者
相似试验
已完成
4 期
the effect of tofacitinib on bone mineral density in patients with rheumatoid arthritisto determine the effect of tofacitinib on boneJPRN-UMIN000027242Division of rheumatology, hiroshima clinic50
撤回
4 期
Effects of Tocilizumab (RoACTEMRA) on biomarkers in synovial tissue of patients with rheumatoid arthritisRheumatiod Arthritis10003816NL-OMON36162Academisch Medisch Centrum20
已完成
不适用
Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor BlockersRheumatoid ArthritisNCT02778789University of Erlangen-Nürnberg Medical School66
已完成
1 期
Tocotrienols and Bone Health of Postmenopausal WomenOsteoporosisNCT02058420Texas Tech University Health Sciences Center78
招募中
不适用
Inhibitory effects of tocilizumab on serum oxidative stress in patients with rheumatoid arthritis -comaparison with other biologic agentsRheumatoid arthritisJPRN-UMIN000018659Toho University School of Medicine60